Compare Stocks

→ Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MBX Microbix Biosystems	C$0.35 -2.8%	C$0.38	C$0.23 ▼ C$0.47	C$47.79M	0.28	74,267 shs	46,025 shs
PDP Invesco Dorsey Wright Momentum ETF	$93.64 0.0%	$95.24	$72.68 ▼ $99.60	$1.21B	1.02	26,631 shs	32,992 shs
PMN ProMIS Neurosciences	$2.00 -7.4%	$2.05	$0.95 ▼ $8.95	$37.92M	0.67	41,086 shs	14,907 shs
RENE Cartesian Growth Co. II	$11.17	$11.09	$10.49 ▼ $11.92	$241.50M	-0.01	46,698 shs	8,158 shs
SBM ProShares Short Basic Materials	$46.38	$46.38	$42.85 ▼ $55.15	$1.86M	N/A	3,024 shs	N/A

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MBX Microbix Biosystems	-1.41%	-6.67%	-9.09%	-10.26%	-11.39%
PDP Invesco Dorsey Wright Momentum ETF	-1.53%	-4.18%	-1.94%	+10.64%	+24.13%
PMN ProMIS Neurosciences	-7.34%	-9.58%	+13.61%	-22.78%	-57.46%
RENE Cartesian Growth Co. II	0.00%	+0.27%	+0.54%	+1.55%	+6.48%
SBM ProShares Short Basic Materials	0.00%	0.00%	0.00%	0.00%	-0.01%

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
MBX Microbix Biosystems	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PMN ProMIS Neurosciences	2.9092 of 5 stars	3.5	4.0	0.0	0.0	3.3	1.7	0.6
RENE Cartesian Growth Co. II	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MBX Microbix Biosystems	3.00	Buy	N/A	N/A
PDP Invesco Dorsey Wright Momentum ETF	0.00	N/A	$95.18	1.65% Upside
PMN ProMIS Neurosciences	3.00	Buy	$8.00	300.00% Upside
RENE Cartesian Growth Co. II	N/A	N/A	N/A	N/A
SBM ProShares Short Basic Materials	0.00	N/A	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MBX Microbix Biosystems	C$22.42M	2.13	C$0.08 per share	4.13	C$0.20 per share	1.75
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	N/A	N/A	N/A	N/A
PMN ProMIS Neurosciences	$10K	3,792.00	N/A	N/A	$0.20 per share	10.00
RENE Cartesian Growth Co. II	N/A	N/A	$0.40 per share	28.07	($0.64) per share	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MBX Microbix Biosystems	C$3.72M	C$0.03	11.67	∞	N/A	16.57%	14.66%	1.87%	5/9/2024 (Estimated)
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	25.46	∞	N/A	N/A	N/A	N/A	N/A
PMN ProMIS Neurosciences	-$13.21M	-$1.13	N/A	N/A	N/A	N/A	N/A	-141.23%	5/20/2024 (Estimated)
RENE Cartesian Growth Co. II	$11.44M	N/A	0.00	∞	N/A	N/A	-65.59%	5.02%	N/A
SBM ProShares Short Basic Materials	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest RENE, PDP, MBX, SBM, and PMN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/1/2024	Q4 2023	PMN ProMIS Neurosciences	N/A	-$0.09	-$0.09	-$0.09	N/A	N/A
2/14/2024	Q1 2024	MBX Microbix Biosystems	N/A	C$0.02	+C$0.02	C$0.02	C$8.10 million	C$8.41 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
MBX Microbix Biosystems	N/A	N/A	N/A	N/A	N/A
PDP Invesco Dorsey Wright Momentum ETF	$0.25	0.27%	N/A	N/A	N/A
PMN ProMIS Neurosciences	N/A	N/A	N/A	N/A	N/A
RENE Cartesian Growth Co. II	N/A	N/A	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A	N/A	N/A

Latest RENE, PDP, MBX, SBM, and PMN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/15/2024	PDP Invesco Dorsey Wright Momentum ETF	Quarterly	$0.0275		3/18/2024	3/19/2024	3/22/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MBX Microbix Biosystems	24.53	8.53	5.57
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	N/A
PMN ProMIS Neurosciences	N/A	1.46	1.46
RENE Cartesian Growth Co. II	N/A	0.22	0.22
SBM ProShares Short Basic Materials	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
MBX Microbix Biosystems	0.42%
PDP Invesco Dorsey Wright Momentum ETF	N/A
PMN ProMIS Neurosciences	50.13%
RENE Cartesian Growth Co. II	58.96%
SBM ProShares Short Basic Materials	N/A

Insider Ownership

Company	Insider Ownership
MBX Microbix Biosystems	14.07%
PDP Invesco Dorsey Wright Momentum ETF	N/A
PMN ProMIS Neurosciences	10.30%
RENE Cartesian Growth Co. II	20.00%
SBM ProShares Short Basic Materials	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
MBX Microbix Biosystems	N/A	136.55 million	N/A	Not Optionable
PDP Invesco Dorsey Wright Momentum ETF	N/A	12.91 million	N/A	Optionable
PMN ProMIS Neurosciences	6	18.96 million	17.01 million	Not Optionable
RENE Cartesian Growth Co. II	N/A	21.62 million	17.30 million	Not Optionable
SBM ProShares Short Basic Materials	N/A	40,000	N/A	Not Optionable

RENE, PDP, MBX, SBM, and PMN Headlines

Source	Headline
	Fundamentals of Materials for Energy and Environmental Sustainability cambridge.org - March 24 at 5:46 PM
	Sh4b set aside for CBC classrooms missing standardmedia.co.ke - February 25 at 10:22 PM
	TTT ProShares UltraPro Short 20+ Year Treasury ETF seekingalpha.com - December 24 at 6:36 PM
	ProShares Short Basic Materials (SBM) finance.yahoo.com - November 23 at 7:46 AM
	All Indices thestreet.com - September 18 at 9:22 PM
	ProShares Short Financials (SEF) investing.com - August 24 at 3:19 PM
	ProShares Short Basic Materials News thestreet.com - August 23 at 11:58 PM
	Volatile Market Conditions Could Drive Investors to Trade investopedia.com - July 23 at 10:52 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Microbix Biosystems

TSE:MBX

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Invesco Dorsey Wright Momentum ETF

NASDAQ:PDP

PowerShares DWA Technical Leaders Portfolio (the Fund) is based on the Dorsey Wright Technical Leaders Index (the Index). The Fund seeks investment results that generally correspond to the price and yield of the Index. The Fund will normally invest at least 90% of its total assets in securities that consists of the Index and American Depositary Receipts (ADRs) based on the securities in the Index. The Index includes approximately 100 the United States-listed companies. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser.

ProMIS Neurosciences

NASDAQ:PMN

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

Cartesian Growth Co. II

NASDAQ:RENE

Cartesian Growth Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. Cartesian Growth Corporation II was incorporated in 2021 and is based in New York, New York.

ProShares Short Basic Materials

NYSEARCA:SBM

ProShares Short Basic Materials (the Fund) seeks daily investment results that correspond to the inverse (opposite) of the daily performance of Dow Jones U.S. Basic Materials Index (the Index). The Index measures the performance of the basic materials industry of the United States equity market. The Fund invests in derivatives as a substitute for directly shorting stocks in order to gain inverse exposure to the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. The Fund also invests in short-term cash instruments that have terms to maturity of less than 397 days and exhibit credit profiles. ProShare Advisors LLC is the investment advisor of the Fund.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial